225 related articles for article (PubMed ID: 25893299)
1. p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer.
Lodillinsky C; Infante E; Guichard A; Chaligné R; Fuhrmann L; Cyrta J; Irondelle M; Lagoutte E; Vacher S; Bonsang-Kitzis H; Glukhova M; Reyal F; Bièche I; Vincent-Salomon A; Chavrier P
Oncogene; 2016 Jan; 35(3):344-57. PubMed ID: 25893299
[TBL] [Abstract][Full Text] [Related]
2. Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kim HJ; Park CI; Park BW; Lee HD; Jung WH
Yonsei Med J; 2006 Jun; 47(3):333-42. PubMed ID: 16807982
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.
Haupt LM; Thompson EW; Trezise AE; Irving RE; Irving MG; Griffiths LR
BMC Cancer; 2006 Jan; 6():18. PubMed ID: 16430785
[TBL] [Abstract][Full Text] [Related]
4. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.
Sugiyama N; Varjosalo M; Meller P; Lohi J; Hyytiäinen M; Kilpinen S; Kallioniemi O; Ingvarsen S; Engelholm LH; Taipale J; Alitalo K; Keski-Oja J; Lehti K
Cancer Res; 2010 Oct; 70(20):7851-61. PubMed ID: 20876804
[TBL] [Abstract][Full Text] [Related]
6. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells.
Polette M; Gilles C; Nawrocki-Raby B; Lohi J; Hunziker W; Foidart JM; Birembaut P
Cancer Res; 2005 Sep; 65(17):7691-8. PubMed ID: 16140936
[TBL] [Abstract][Full Text] [Related]
7. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
[TBL] [Abstract][Full Text] [Related]
8. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J
J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822
[TBL] [Abstract][Full Text] [Related]
9. Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance.
Lodillinsky C; Fuhrmann L; Irondelle M; Pylypenko O; Li XY; Bonsang-Kitzis H; Reyal F; Vacher S; Calmel C; De Wever O; Bièche I; Lacombe ML; Eiján AM; Houdusse A; Vincent-Salomon A; Weiss SJ; Chavrier P; Boissan M
Oncogene; 2021 Jun; 40(23):4019-4032. PubMed ID: 34012098
[TBL] [Abstract][Full Text] [Related]
10. Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.
Farooqui M; Bohrer LR; Brady NJ; Chuntova P; Kemp SE; Wardwell CT; Nelson AC; Schwertfeger KL
Mol Cancer; 2015 Jul; 14():138. PubMed ID: 26215578
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation.
Muñoz-Nájar UM; Neurath KM; Vumbaca F; Claffey KP
Oncogene; 2006 Apr; 25(16):2379-92. PubMed ID: 16369494
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material.
Haupt LM; Irving RE; Weinstein SR; Irving MG; Griffiths LR
Mol Cell Probes; 2008 Apr; 22(2):83-9. PubMed ID: 17669621
[TBL] [Abstract][Full Text] [Related]
13. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
14. Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1.
Ota I; Li XY; Hu Y; Weiss SJ
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20318-23. PubMed ID: 19915148
[TBL] [Abstract][Full Text] [Related]
15. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
[TBL] [Abstract][Full Text] [Related]
16. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
[TBL] [Abstract][Full Text] [Related]
17. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
18. CLIC3 controls recycling of late endosomal MT1-MMP and dictates invasion and metastasis in breast cancer.
Macpherson IR; Rainero E; Mitchell LE; van den Berghe PV; Speirs C; Dozynkiewicz MA; Chaudhary S; Kalna G; Edwards J; Timpson P; Norman JC
J Cell Sci; 2014 Sep; 127(Pt 18):3893-901. PubMed ID: 25015290
[TBL] [Abstract][Full Text] [Related]
19. Membrane type 1-matrix metalloproteinase promotes human prostate cancer invasion and metastasis.
Cao J; Chiarelli C; Kozarekar P; Adler HL
Thromb Haemost; 2005 Apr; 93(4):770-8. PubMed ID: 15841326
[TBL] [Abstract][Full Text] [Related]
20. Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13.
Sendon-Lago J; Seoane S; Eiro N; Bermudez MA; Macia M; Garcia-Caballero T; Vizoso FJ; Perez-Fernandez R
Breast Cancer Res; 2014 Dec; 16(6):505. PubMed ID: 25527274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
